Abstract

The coronavirus disease of 2019 (COVID-19) discovered in China in early December 2019. The Saudi Food and Drug Authority approved the registration of the Pfizer-BioNTech COVID-19 vaccine in Saudi Arabia on December 10, 2020, and on May 10, 2021, Pfizer-BioNTech was given emergency authorization for use of the vaccine in children aged 12 to 15 years. Saudi Arabia’s Ministry of Health started the vaccination phase for ages 12 to 18 years for the Pfizer-BioNTech COVID-19 vaccine on June 27, 2021. An insulin-dependent diabetic 15-year-old female patient admitted to the medical ward diagnosed with acute pancreatitis nine days after being administered her first dose of the Pfizer-BioNTech COVID-19 vaccine. She presented with an amylase level of 340 U/L, lipase level of 937 U/L. She was discharged after eight days of hospitalization with no complications. Medical investigations were unable to link the diagnosis to any known etiology. Medical journals have reported numerous cases of acute pancreatitis in the adult population after Pfizer-BioNTech COVID-19 vaccination. We believe that our case is the first to present with acute pancreatitis after the first dose of the Pfizer-BioNTech COVID-19 vaccine in a teenager population.

Keywords: Teenager Acute pancreatitis Vaccine Pfizer-BioNTech

References

  1. Mohan BS, Nambiar V. COVID-19: An insight into SARS-CoV-2 pandemic originated at Wuhan city in Hubei Province of China. J Infect Dis Epidemiol. 2020;6:146.
  2. Pfizer-BioNTech COVID-19 Vaccine Briefing. 2020. Available from: https://www.fda.gov/media/144246/download [Last accessed on 2021 Oct 05]
  3. Emergency Use Authorization for Vaccines to Prevent COVID-19. 2020. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine [Last accessed on 2021 Oct 05]
  4. Food and Drug Administration. Emergency Use Authorization letter for Pfizer-BioNTech COVID-19 Vaccine. 2020. Emergency Use Authorization letter for Pfizer-BioNTech COVID-19 Vaccine. Silver Spring, Maryland: Food and Drug Administration; Available from: https://www.fda.gov/media/144412/download [Last accessed on 2021 Oct 05]
  5. Saudi Food and Drug Authority Approving Pfizer-BioNTech COVID-19 Vaccine. 2020. Available from: https://www.sfda.gov.sa/en/node/73864 [Last accessed on 2021 Oct 05]
  6. Saudi Arabia's Ministry of Health Vaccination of Age 12-18 Years Old. Available from: https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2021-06-27-008.aspx [Last accessed on 2021 Oct 05]
  7. Al-Karawi MA, Mohamed AE, Dafala MM, Yasawi MI, Ghadour ZM. Acute pancreatitis in Saudi patients. Saudi J Gastroenterol. 2001;7:30-3.
  8. Al-Awady HM. The etiological factors in 73 cases of acute pancreatitis. Int Surg. 1981;66:145-8.
  9. Gapp J, Chandra S. Acute pancreatitis Treasure Island, FL: StatPearls Publishing; 2021.
  10. Lithell H, Vessby B, Walldius G, Carlson LA. Hypertriglyceridemia--acute pancreatitis--ischemic heart disease. A case study in a pair of monozygotic twins. Acta Med Scand. 1987;221:311-6.
  11. Seth A, Rajpal S, Saigal T, Bienvenu J, Sheth A, Alexander JS, et al. Diabetic ketoacidosis-induced hypertriglyceridemic acute pancreatitis treated with plasmapheresis-recipe for biochemical disaster management. Clin Med Insights Gastroenterol. 2014;7:51-3.
  12. Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: Observations in 100 consecutive episodes of DKA. Am J Gastroenterol. 2000;10:2795-800.
  13. Güngör B, Çaglayan K, Polat C, Seren D, Erzurumlu K, Malazgirt Z. The predictivity of serum biochemical markers in acute biliary pancreatitis. Int Schl Res Notices. 2011;2011:2796075.
  14. Ma YB, Hu J, Duan YF. Acute pancreatitis connected with hypercalcemia crisis in hyperparathyroidism: A case report. World J Clin Cases. 2019;7:2367-73.
  15. Kumar A, Kumar PG, Pujahari AK, Sampath S. Hypercalcemia related pancreatitis. Med J Armed Forces India. 2010;66:385-6.

Comments & Peer Review


Must Read